1. Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarction. Issue 2 (25th August 2021) Authors: Wang, Anne; Flanagan, John; Arver, Stefan; Norhammar, Anna; Näsman, Per; Rydén, Lars; Mellbin, Linda G Editors: Larsson, Susanna C Journal: European Heart Journal Open Issue: Volume 1:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?. (June 2020) Authors: Ferrannini, Giulia; Svenungsson, Elisabet; Kjellström, Barbro; Elvin, Kerstin; Grosso, Giorgia; Näsman, Per; Rydén, Lars; Norhammar, Anna Journal: Diabetes & vascular disease research Issue: Volume 17:Number 3(2020:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of peptidoglycan recognition protein 1 to post‐myocardial infarction and periodontal inflammation: A subgroup report from the PAROKRANK (Periodontal Disease and the Relation to Myocardial Infarction) study. Issue 9 (19th July 2022) Authors: Rathnayake, Nilminie; Gustafsson, Anders; Sorsa, Timo; Norhammar, Anna; Bostanci, Nagihan Journal: Journal of periodontology Issue: Volume 93:Issue 9(2022) Page Start: 1325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study. Issue 6 (23rd March 2021) Authors: Lam, Carolyn S. P.; Karasik, Avraham; Melzer‐Cohen, Cheli; Cavender, Matthew A.; Kohsaka, Shun; Norhammar, Anna; Thuresson, Marcus; Chen, Hungta; Wittbrodt, Eric; Fenici, Peter; Kosiborod, Mikhail Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 6(2021) Page Start: 1431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis. Issue 9 (September 2017) Authors: Birkeland, Kåre I; Jørgensen, Marit E; Carstensen, Bendix; Persson, Frederik; Gulseth, Hanne L; Thuresson, Marcus; Fenici, Peter; Nathanson, David; Nyström, Thomas; Eriksson, Jan W; Bodegård, Johan; Norhammar, Anna Journal: Lancet Issue: Volume 5:Issue 9(2017) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort. (January 2019) Authors: Smáradóttir, Maria Isabel; Catrina, Sergiu-Bogdan; Brismar, Kerstin; Norhammar, Anna; Gyberg, Viveca; Mellbin, Linda G Journal: Diabetes & vascular disease research Issue: Volume 16:Number 1(2019:Jan.) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities – A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort. (March 2017) Authors: Smaradottir, Maria Isabel; Ritsinger, Viveca; Gyberg, Viveca; Norhammar, Anna; Näsman, Per; Mellbin, Linda G Journal: Diabetes & vascular disease research Issue: Volume 14:Number 2(2017:Mar.) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study. (July 2016) Authors: Arnetz, Lisa; Hage, Camilla; Brismar, Kerstin; Catrina, Sergiu-Bogdan; Norhammar, Anna; Lundman, Pia; Wallander, Märit; Ryden, Lars; Mellbin, Linda Journal: Diabetes & vascular disease research Issue: Volume 13:Number 4(2016:Jul.) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries. Issue 7 (19th April 2022) Authors: Norhammar, Anna; Bodegard, Johan; Eriksson, Jan W.; Haller, Hermann; Linssen, Gerard C. M.; Banerjee, Amitava; Karasik, Avraham; Mamouris, Pavlos; Tangri, Navdeep; Taveira‐Gomes, Tiago; Maggioni, Aldo P.; Botana, Manuel; Thuresson, Marcus; Okami, Suguru; Yajima, Toshitaka; Kadowaki, Takashi; Birk... Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 7(2022) Page Start: 1277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study. Issue 5 (6th February 2019) Authors: Norhammar, Anna; Bodegård, Johan; Nyström, Thomas; Thuresson, Marcus; Nathanson, David; Eriksson, Jan W. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 5(2019) Page Start: 1136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗